| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $34,064,095 ) (Continued on the next page) |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32HD117733 | Clinical Pharmacology Training Program | 000 | 1 | NIH | 5/21/2025 | $208,150 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI160189 | IL-37: a novel regulator of inflammation in CNS autoimmunity | 000 | 4 | NIH | 4/23/2025 | $390,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA256945 | Mechanisms of cell death in cutaneous melanoma | 000 | 5 | NIH | 4/23/2025 | $430,039 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA256945 | Mechanisms of cell death in cutaneous melanoma | 001 | 5 | NIH | 6/4/2025 | $47,783 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR078440 | Caspase-1 Activation by the Inflammasomes | 000 | 5 | NIH | 4/30/2025 | $549,226 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA255792 | Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer | 000 | 5 | NIH | 6/12/2025 | $653,812 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI162971 | IRF7-mediated development of autoreactive B cells and SLE | 002 | 5 | NIH | 5/21/2025 | $543,950 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236853 | BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | 001 | 6 | NIH | 6/24/2025 | $36,418 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236853 | BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | 000 | 6 | NIH | 11/25/2024 | $327,764 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI149795 | Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses | 000 | 5 | NIH | 12/11/2024 | $378,300 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM131832 | Molecular Mechanisms of Mitochondrial Transcription and Replication | 003 | 7 | NIH | 6/5/2025 | $544,190 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY035772 | Solute Transporters and Retinal Health | 000 | 1 | NIH | 4/1/2025 | $595,302 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL140064 | Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy | 002 | 6 | NIH | 6/12/2025 | $3,004 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL140064 | Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy | 000 | 6 | NIH | 1/13/2025 | $595,123 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY021784 | Paradigms of maintaining anterior segment homeostasis | 000 | 14 | NIH | 4/11/2025 | $572,513 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156496 | Biogenesis and function of cyclic phosphate-containing RNAs | 000 | 1 | NIH | 2/3/2025 | $429,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS134987 | Neuroimaging and Connectome Analysis as a Diagnostic and Prognostic Biomarker of SCI Induced Neuropathic Pain | 000 | 2 | NIH | 4/14/2025 | $564,509 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R00AG066938 | Molecular mechanisms of Werner syndrome helicase in genome stability and aging | 000 | 5 | NIH | 12/16/2024 | $224,100 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | UG1CA233341 | Sidney Kimmel Cancer Center LAPS Institutional Collaboration | 001 | 5 | NIH | 4/30/2025 | $239,078 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 001 | 3 | NIH | 6/4/2025 | $58,972 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 000 | 3 | NIH | 11/15/2024 | $530,756 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR076941 | Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium | 001 | 5 | NIH | 6/2/2025 | $46,055 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR076941 | Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium | 000 | 5 | NIH | 12/11/2024 | $592,145 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM151536 | Mitochondrial Calcium Uniporter in Signaling and Dynamics | 000 | 3 | NIH | 6/12/2025 | $421,776 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AR084212 | Gene Therapy for PXE: Breaking the Barrier of Ectopic Calcification | 001 | 2 | NIH | 4/28/2025 | $0 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AR084212 | Gene Therapy for PXE: Breaking the Barrier of Ectopic Calcification | 000 | 2 | NIH | 4/16/2025 | $185,328 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS112504 | Investigating the Role and Regulation of the MAP7 Family Proteins in Axonal Morphogenesis and Function | 000 | 5 | NIH | 11/27/2024 | $385,296 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL122124 | Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics | 000 | 8 | NIH | 11/21/2024 | $492,718 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY035771 | Molecular function of extracellular vimentin in regulating the response to lens wounding | 000 | 2 | NIH | 4/11/2025 | $451,480 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HG013302 | Twice reading of RNA by direct nanopore sequencing | 001 | 2 | NIH | 4/28/2025 | $84,306 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HG013302 | Twice reading of RNA by direct nanopore sequencing | 000 | 2 | NIH | 4/9/2025 | $758,754 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173113 | Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | 000 | 2 | NIH | 3/25/2025 | $509,870 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 001 | 4 | NIH | 6/11/2025 | $54,001 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 4 | NIH | 1/9/2025 | $486,021 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI156384 | Role of IL-7R in CNS autoimmunity | 000 | 4 | NIH | 11/26/2024 | $378,300 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R33HL173910 | RNA-based therapeutics for hemostasis and thrombosis | 000 | 2 | NIH | 4/15/2025 | $491,398 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 003 | 5 | NIH | 6/12/2025 | -$44,845 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 001 | 5 | NIH | 4/10/2025 | -$245,704 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 000 | 5 | NIH | 1/1/2025 | $321,165 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082460 | The role of endogenous low molecular weight mineralization inhibitors in spine health | 000 | 2 | NIH | 11/13/2024 | $599,407 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG078609 | ASK1 inhibition as a novel strategy to regulate immune function and promote regeneration | 000 | 3 | NIH | 1/17/2025 | $646,492 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173436 | Platelets as regulator of non-neurological complications of ischemic stroke | 000 | 1 | NIH | 6/12/2025 | $779,952 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS132056 | Mitochondrial Calcium and Neuronal Health | 000 | 3 | NIH | 5/30/2025 | $623,535 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS121143 | Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS | 000 | 3 | NIH | 4/4/2025 | $351,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES034077 | The Role of m6A-RNA Methylation in Memory Formation and Recall and Its Modulation and Influence on Long-Term Outcomes as a Consequence of Early Life Lead Exposure | 000 | 3 | NIH | 4/15/2025 | $549,132 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK136992 | Hypercalciuria and Abnormal Bone in the Genetic Hypercalciuric Stone-Forming Rats | 000 | 2 | NIH | 3/27/2025 | $410,872 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES033197 | METTL3 in chromium-induced angiogenesis and carcinogenesis | 000 | 4 | NIH | 1/14/2025 | $519,475 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA267549 | WNT pathway-driven anti-estrogen therapy resistance in breast cancer | 001 | 3 | NIH | 5/22/2025 | $54,969 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA267549 | WNT pathway-driven anti-estrogen therapy resistance in breast cancer | 000 | 3 | NIH | 4/14/2025 | $494,727 |
|
